Pfizer Inc
NDC Database

Pfizer Inc

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 10
  • Latest Marketing Date 2022-07-11
  • Data Source FDA
  • First Marketing Date 2019-11-21
Company Overview

Company

Pfizer Inc

Country

U.S.A

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Pfizer Inc

235 East 42nd Street New York, NY 10017

U.S.A

www.pfizer.com/ View on Map
NDC Records ( 10 records )
2019
21 Nov
Drug for Further Processing NDC: 65427-155

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

10 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-155

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-156

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

20 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-156

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-157

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

40 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-157

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-158

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

80 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-158

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-255

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

10 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-255

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-256

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

20 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-256

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-257

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

40 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-257

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
21 Nov
Drug for Further Processing NDC: 65427-258

Nonproprietary Name

atorvastatin calcium

Dosage Form

TABLET, FILM COATED

Strength

80 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-258

Substance

ATORVASTATIN CALCIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-21

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
11 Jul
Drug for Further Processing NDC: 65427-306

Nonproprietary Name

azithromycin dihydrate

Dosage Form

TABLET, FILM COATED

Strength

250 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-306

Substance

AZITHROMYCIN DIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-07-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
11 Jul
Drug for Further Processing NDC: 65427-416

Nonproprietary Name

azithromycin dihydrate

Dosage Form

TABLET, FILM COATED

Strength

500 mg/1

Labeler

Pfizer Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-416

Substance

AZITHROMYCIN DIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-07-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    18 View
  • EDQM CEP
    63 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    10 View
  • FDA Approved Drugs Database
    856 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
10 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

65427-155

Nonproprietary Name

atorvastatin calcium

Labeler

Pfizer Pharmaceuticals LLC

Dosage Form

TABLET, FILM COATED

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.